HBK Investments’s Verona Pharma VRNA Stock Holding History

HBK Investments’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,263,576	Closed	-$455M	–	313
2025 Q3	$455M	Buy	+4,263,576	New	+$445M	4.99%	2

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

HBK Investments's VRNA Position: Q4 2025 in Review

HBK Investments sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 4,263,576 shares — an estimated $455M sold.

HBK Investments first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $455M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

HBK Investments reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
HBK Investments sold 4,263,576 Verona Pharma shares in Q4 2025, an estimated $455M.
HBK Investments first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
HBK Investments's Verona Pharma position peaked at $455M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on HBK Investments's 13F filing for Q4 2025, filed 17 Feb 2026.